Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Blocking mTORC1 reduces skin tumor growth in mice.

Male pattern baldness may be linked to prostate cancer risk.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Cancer prevention has advanced significantly, with some strategies proving successful.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Jatropha dioica may have antiviral, antifungal, and other medicinal properties, but more research is needed.

Finasteride may reduce prostate tumor cell invasion and spread.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Presurgical models can effectively and affordably screen cancer prevention agents.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

No treatment fully prevents hair loss from chemotherapy yet.

Natural antioxidants and phytotherapeutic molecules may help prevent cancer.

Cancer prevention is crucial, with a focus on research and improved screening methods.

Imuvert can prevent some chemotherapy-induced hair loss.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Cooling with antioxidants helps protect hair during chemotherapy.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Mild oxidative stress can prevent hair loss from chemotherapy.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.